US 12161643
Stable formulations of SHR0302
granted A61KA61K31/519A61K31/52
Quick answer
US patent 12161643 (Stable formulations of SHR0302) held by ARCUTIS BIOTHERAPEUTICS, INC. expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCUTIS BIOTHERAPEUTICS, INC.
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/519, A61K31/52, A61K47/08, A61K47/12